MacroGenics | MGNX - Actif À Court Terme

Prix De L'Action
3.60
Variation Quotidienne
0.16 4.65%
Mensuellement
7.78%
Annuel
179.07%
Q2 Prévisions
3.50




Actif À Court Terme Changement Date
AbbVie USD 29.06B 523M 2025-12
Amgen USD 29.06B 1.17B 2025-12
AstraZeneca USD 28.72B 1.22B 2025-12
Biogen USD 8.97B 37.5M 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Daiichi Sankyo JPY 2.1T 218.5B 2025-12
Eli Lilly USD 55.63B 6.44B 2025-12
Genmab DKK 2.88B 1.59B 2025-12
Geron USD 520.27M 2.07M 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
J&J USD 55.62B 1.01B 2025-12
Karyopharm Therapeutics USD 103.15M 13.4M 2025-12
MacroGenics USD 219.94M 12.15M 2025-12
Merck USD 47.56B 10.49B 2025-09
Pfizer USD 46.92B 3.22B 2025-09
Puma Biotechnology USD 143.58M 7M 2025-09
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Roche Holding CHF 38.73B 3.03B 2025-12
Xencor USD 599.82M 81.38M 2025-12